Q4 Rally Has Roots, but the Same Valuation Hurdle Remains

What happened

Microsoft’s Q4 results ignited a sharp rally as Azure growth accelerated to 43% and first-quarter guidance pointed to roughly 45% constant-currency expansion, easing concerns that AI spending lacked near-term revenue backing. Copilot monetization deepened, with paid seats surpassing 30 million and usage-based billing gaining traction, while a $678 billion commercial backlog provided further contract visibility. The Seeking Alpha article frames the surge as fundamental de-risking rather than a dead-cat bounce, citing consumption-based AI pricing that may lift the long-term enterprise software revenue ceiling. However, our deep-value analysis maintains a WAIT rating, noting that the stock near $500 already discounts sustained strength and that capex exceeding $50 billion next quarter keeps cash-conversion risk front and center. The central debate now is whether Azure can maintain mid-40s growth and whether margins can hold as massive capacity expansion unfolds.

Implication

Microsoft’s Q4 rally looks fundamentally grounded, as Azure acceleration and Copilot uptake suggest AI investment is translating into real revenue. Yet the stock’s elevated multiple and projected capex surge leave little room for missteps; Azure growth below the ~45% guide or margin erosion would quickly undermine the de-risking narrative. The shift to consumption-based AI billing expands the addressable revenue envelope but also ties the payout to sustained usage spikes, which are unproven at scale. For investors, the recent strength reduces the probability of a near-term value trap but does not eliminate the risk that heavy spending dilutes returns before the full payoff materializes. The WAIT rating stands: consider buying only on pullbacks toward $460 or if Azure growth and margins stay robust through FY27 Q1.

Thesis delta

The Seeking Alpha article reinforces that Azure acceleration and consumption-based AI pricing are fundamentally backing the rally, but this was already captured in our WAIT thesis that strong demand is priced in. It does not resolve the core tension between high valuation and heavy capex, so the wait for clearer proof of capital efficiency remains warranted.